AIR LIQUID INDUSTRIAL US LP
PharmaAIR LIQUID INDUSTRIAL US LP is a pharmaceutical company with 1 FDA-approved products.
AIR LIQUID INDUSTRIAL US LP's Key Drugs
AIR LIQUID INDUSTRIAL US LP's core commercial portfolio centers on OXYGEN, USP — its most strategically important drugs approved in the last 15 years.
AIR LIQUID INDUSTRIAL US LP's Recent FDA Approvals
New NDA/BLA approvals for AIR LIQUID INDUSTRIAL US LP over the last two years — novel drugs only, excluding generics and label supplements.
AIR LIQUID INDUSTRIAL US LP's Therapeutic Areas
Disease areas where AIR LIQUID INDUSTRIAL US LP has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
AIR LIQUID INDUSTRIAL US LP Pipeline Snapshot
Active clinical trials for AIR LIQUID INDUSTRIAL US LP across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • OXYGEN, USP leads revenue
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2013-06-16
- Latest
- 2013-06-16
- Applications
- 2